Statins in coronary artery disease

Statins are the family of drugs that act in the liver to stop or prevent the enzyme reaction that is vital for the production of endogenous cholesterol.

STATINS is the popular short-form name of a family of drugs called the HMG CoA reductase. This drug, which is essentially a fungal metabolite, was discovered in Japan in 1967. It has indeed revolutionised the treatment of coronary artery disease (CAD). It allows us to effectively and predictably lower cholesterol in the blood, thereby lessening heart artery blockage and clinical events from heart artery blockage, like heart attacks, angina and strokes.